By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Johannes Vermeerplain 9-1

Amsterdam      The Netherlands
Phone: 31-20-6645500 Fax: n/a



Company News
French Health System Approves Reimbursement Of QIAGEN N.V. (QGEN)'s QuantiFERON Latent TB Test 6/22/2017 6:19:40 AM
QIAGEN N.V. (QGEN)'s QuantiFERON-TB Gold Plus Gains FDA Approval 6/8/2017 7:42:12 AM
FDA Green Lights QIAGEN N.V. (QGEN)'s CMV Testing on Automated QIAsymphony Platform 6/6/2017 6:44:28 AM
Bristol-Myers Squibb (BMY) And QIAGEN N.V. (QGEN) Partner on Cancer Research 6/5/2017 6:51:41 AM
QIAGEN N.V. (QGEN) Partners With Maccura To Localize And Commercialize Genereader NGS System In China 5/2/2017 10:14:11 AM
New Research Suggests Potential For Additional Clinical Utility Of QIAGEN N.V. (QGEN)'s QuantiFERON-TB Gold Plus 4/13/2017 11:43:42 AM
QIAGEN N.V. (QGEN) To Report First Quarter 2017 Results 4/6/2017 8:56:00 AM
QIAGEN N.V. (QGEN)'s GeneReader NGS System Gains Further Validation In Oncology Research Applications With New Independent Performance Review Data 4/3/2017 9:35:14 AM
QIAGEN N.V. (QGEN) Expands Liquid Biopsy Pipeline With AR-V7 Test In Prostate Cancer 4/3/2017 9:29:19 AM
QIAGEN N.V. (QGEN) Joins CANCER-ID Consortium For Liquid Biopsy Workflows 3/31/2017 9:46:19 AM